Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

Kapfhammer, Hans-Peter 2008. Persönlichkeitsstörungen – Diagnostische Konzepte – Neurobiologie-Pharmakotherapie. Psychiatrie und Psychotherapie, Vol. 4, Issue. 2, p. 37.

Tyrer, Peter 2009. Borderline personality disorder: A diagnosis with friends bound by loyalty alone. Personality and Mental Health, Vol. 3, Issue. 2, p. 124.

Tyrer, Peter 2009. Psychiatry: An evidence-based text. p. 704.

Millet, Bruno Vanelle, Jean-Marie and Benyaya, Joseph 2010. Prescrire les psychotropes. p. 173.

Hadjipavlou, George and Ogrodniczuk, John S 2010. Promising Psychotherapies for Personality Disorders. The Canadian Journal of Psychiatry, Vol. 55, Issue. 4, p. 202.

Mircoli, Giuliana Bascioni, Sara Lucarelli, Chiara and Bellantuono, Cesario 2010. Antipsicotici atipici nel trattamento farmacologico del disturbo borderline di personalità: una revisione sistematica. Quaderni Italiani di Psichiatria, Vol. 29, Issue. 2, p. 51.

Stoffers, Jutta Völlm, Birgit A Rücker, Gerta Timmer, Antje Huband, Nick and Lieb, Klaus 2010. Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews,

Feurino, Louis and Silk, Kenneth R. 2011. State of the Art in the Pharmacologic Treatment of Borderline Personality Disorder. Current Psychiatry Reports, Vol. 13, Issue. 1, p. 69.

Paris, Joel 2011. Pharmacological treatments for personality disorders. International Review of Psychiatry, Vol. 23, Issue. 3, p. 303.

Tyrer, Peter and Silk, Kenneth R. 2011. A comparison of UK and US guidelines for drug treatment in borderline personality disorder. International Review of Psychiatry, Vol. 23, Issue. 4, p. 388.

Pelissolo, A. and Jost, F. 2011. Pharmacothérapie des troubles de la personnalité. Annales Médico-psychologiques, revue psychiatrique, Vol. 169, Issue. 9, p. 592.

Johnson, Monique D. Kennedy, Robert S. Binford, Sandra Haas and Ansted, Christina J. 2011. Meeting Highlights on Psychiatric Clinical Challenges and Advancing the Science of Treatment: The 3rd Annual Chair Summit. Health Outcomes Research in Medicine, Vol. 2, Issue. 3, p. e169.

Ripoll, Luis H. Triebwasser, Joseph and Siever, Larry J. 2011. Evidence-based pharmacotherapy for personality disorders. The International Journal of Neuropsychopharmacology, Vol. 14, Issue. 09, p. 1257.

Leichsenring, Falk Leibing, Eric Kruse, Johannes New, Antonia S and Leweke, Frank 2011. Borderline personality disorder. The Lancet, Vol. 377, Issue. 9759, p. 74.

Ingenhoven, Theo J.M. and Duivenvoorden, Hugo J. 2011. Differential Effectiveness of Antipsychotics in Borderline Personality Disorder. Journal of Clinical Psychopharmacology, Vol. 31, Issue. 4, p. 489.

Vita, Antonio De Peri, Luca and Sacchetti, Emilio 2011. Antipsychotics, Antidepressants, Anticonvulsants, and Placebo on the Symptom Dimensions of Borderline Personality Disorder. Journal of Clinical Psychopharmacology, Vol. 31, Issue. 5, p. 613.

Herpertz, S. C. Habermeyer, V. and Bronisch, T. 2011. Psychiatrie, Psychosomatik, Psychotherapie. p. 2187.

Carvajal, Alfonso Martín Arias, Luis H. and Jimeno, Natalia 2011. A worldwide yearly survey of new data in adverse drug reactions. Vol. 33, Issue. , p. 89.

Bellino, Silvio Rinaldi, Camilla Bozzatello, Paola and Bogetto, Filippo 2011. Recent approaches to pharmacotherapy of personality disorders. Neuropsychiatry, Vol. 1, Issue. 3, p. 259.

Houston, John Dharia, Sweta Bishop, Jeffrey R. Ellingrod, Vicki L. Fijal, Bonnie Jacobson, Jennie G. and Hoffmann, Vicki P. 2011. Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women. Psychiatry Research, Vol. 187, Issue. 1-2, p. 74.